1. 1401 Metronomic topotecan causes a favorable type of therapy-inducedsenescence and prolongs survival in MYCN amplified neuroblastoma xenografts. (September 2015) Authors: Taschner-Mandl, S.; Schwarz, M.; Blaha, J.; Kauer, M.; Kromp, F.; Frank, N.; Rifatbegovic, F.; Weiss, T.; Ladenstein, R.; Hohenegger, M.; Ambros, I.; Ambros, P. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S198 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Glycosylation of the cytokine co-receptor gp130 reveals a rapid protein turnover, which gives raise to biased signalling in human melanoma cells from different disease stages. (March 2019) Authors: Svoboda, K.; Wasinger, C.; Mayer, S.; Hohenegger, M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S11 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The nonessential amino acid proline enhances migration and proliferation of human melanoma cells. (March 2019) Authors: Mayr, K.; Wasinger, C.; Mayer, S.; Hohenegger, M. Journal: European journal of cancer Issue: Volume 110(2019)Supplement 1 Page Start: S10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗